CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1

Gain-of-function mutations in KIT, a member of the receptor type tyrosine kinases, are observed in certain neoplasms, including mast cell tumors (MCTs) and acute myelogenous leukemias (AMLs). A MCT line HMC1.2 harboring the KIT mutation was reported to express CD72, which could suppress the cell pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Tatsuki R., Kumanogoh, Atsushi, Hirata, Masahiro, Moriyoshi, Koki, Ueshima, Chiyuki, Kawahara, Masahiro, Tsuruyama, Tatsuaki, Haga, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980566/
https://www.ncbi.nlm.nih.gov/pubmed/24713856
http://dx.doi.org/10.1038/srep02861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980566/
https://www.ncbi.nlm.nih.gov/pubmed/24713856
http://dx.doi.org/10.1038/srep02861

Ejemplares similares